Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Gross Profit (2020 - 2025)

Historic Gross Profit for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $4.9 million.

  • Rapid Micro Biosystems' Gross Profit rose 1691.11% to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.8 million, marking a year-over-year increase of 4759.14%. This contributed to the annual value of $14.8 million for FY2024, which is 6075.89% up from last year.
  • Rapid Micro Biosystems' Gross Profit amounted to $4.9 million in Q3 2025, which was up 1691.11% from $4.1 million recorded in Q2 2025.
  • In the past 5 years, Rapid Micro Biosystems' Gross Profit ranged from a high of $5.2 million in Q4 2024 and a low of $250000.0 during Q4 2022
  • For the 5-year period, Rapid Micro Biosystems' Gross Profit averaged around $2.7 million, with its median value being $2.7 million (2021).
  • As far as peak fluctuations go, Rapid Micro Biosystems' Gross Profit crashed by 8750.0% in 2022, and later skyrocketed by 117040.0% in 2023.
  • Over the past 5 years, Rapid Micro Biosystems' Gross Profit (Quarter) stood at $1.9 million in 2021, then tumbled by 86.51% to $250000.0 in 2022, then surged by 1170.4% to $3.2 million in 2023, then surged by 64.86% to $5.2 million in 2024, then decreased by 5.6% to $4.9 million in 2025.
  • Its last three reported values are $4.9 million in Q3 2025, $4.1 million for Q2 2025, and $4.5 million during Q1 2025.